Description
The study shows LRRK2 responds to lysosomal swelling as a volume/mechanical stress sensor, but the specific molecular machinery that detects membrane distension and transmits this signal to activate LRRK2 kinase activity remains unknown. Understanding this mechanosensing pathway is critical for therapeutic targeting in LRRK2-linked Parkinson’s disease.
Gap type: unexplained_observation Source paper: Lysosomal swelling triggers LRRK2 activity. (2026, bioRxiv : the preprint server for biology, PMID:41427358)
Resolution criteria
Resolution requires: (1) In vitro reconstitution with purified lysosomes demonstrating that osmotic swelling (0-500 mOsm range) activates LRRK2 kinase activity (pS935 phosphorylation) in dose-dependent manner with EC50 determination; (2) Protein interaction network mapping during lysosomal swelling (BioID or IP-MS) identifying >=2 membrane proteins or calcium channels (TRPML, OPA1) that physically interact with LRRK2 and are required for swelling-induced activation; (3) Genetic validation: knockout or mutation of >=2 identified sensors prevents LRRK2 activation during lysosomal swelling in cells. Lysosomal swelling without molecular sensor identification is insufficient.
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:23.402219+00:00”, “resolution_summary”: “Resolved by hypothesis h-dd0fe43949: A downstream LRRK2-Rab10-JIP4 lysosomal stress loop promotes alpha-synuclein release and propagation. Supporting evidence includes debate sess_SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867_20260416-135352.”, “match_counts”: {“hypothesis_matches”: 4, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-dd0fe43949”, “title”: “A downstream LRRK2-Rab10-JIP4 lysosomal stress loop promotes alpha-synuclein release and propagation”, “score”: 0.438, “reason”: “9 token overlaps; entity overlap: lrrk2, lrrk2-”, “analysis_id”: “SDA-2026-04-25-gapdebate-9180363b7c”, “target_gene”: “LRRK2,RAB10,JIP4,SNCA”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.68, “confidence_score”: 0.68, “status”: “proposed”, “pubmed_evidence_ids”: [“33177079”, “33749710”, “34236893”, “34555357”, “38307024”]}, {“id”: “h-d4ac0303f6”, “title”: “G2019S primarily raises baseline LRRK2 kinase activity rather than amplifying lysosomal swelling gain”, “score”: 0.256, “reason”: “6 token overlaps; entity overlap: lrrk2”, “analysis_id”: “SDA-2026-04-25-gapdebate-9180363b7c”, “target_gene”: “LRRK2”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.79, “confidence_score”: 0.32, “status”: “proposed”, “pubmed_evidence_ids”: [“23066449”, “34125248”, “34686322”, “35580815”, “35907404”]}, {“id”: “h-a0269f3c81”, “title”: “G2019S Acts as Lysosomal Volume-Sensing Amplifier via Enhanced RAB29-Dependent Recruitment (H1)”, “score”: 0.255, “reason”: “6 token overlaps; entity overlap: lrrk2”, “analysis_id”: “SDA-2026-04-23-gap-debate-20260417-033119-54941818”, “target_gene”: “LRRK2,RAB29”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.73, “confidence_score”: 0.72, “status”: “proposed”, “pubmed_evidence_ids”: [“28165311”, “30635564”, “33135724”, “33177079”, “33448356”]}, {“id”: “h-75fd56f128”, “title”: “RAB29 Is the Critical Molecular Switch That Determines Whether LRRK2 Signal Amplification Occurs (H4)”, “score”: 0.22, “reason”: “4 token overlaps; entity overlap: lrrk2”, “analysis_id”: “SDA-2026-04-23-gap-debate-20260417-033119-54941818”, “target_gene”: “RAB29”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.71, “confidence_score”: 0.7, “status”: “proposed”, “pubmed_evidence_ids”: [“28067317”, “30635564”, “31743699”, “33135724”, “33177079”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867_20260416-135352”, “title”: “While the study establishes LRRK2 as a lysosomal swelling sensor and notes that lysosomal swelling occurs in LRRK2-linked diseases, it doesn’t directly test whether pathogenic LRRK2 mutations alter this volume-sensing function. This connection is crucial for understanding how LRRK2 mutations cause Parkinson’s disease and related disorders.\n\nGap type: open_question\nSource paper: Lysosomal swelling triggers LRRK2 activity. (2026, bioRxiv : the preprint server for biology, PMID:41427358)”, “score”: 0.84, “reason”: “19 token overlaps; entity overlap: lrrk2, lrrk2-, pmid”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867”, “quality_score”: 0.85, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-06-gap-pubmed-20260406-041428-4c4414ad_task_9aae8fc5”, “title”: “The study shows stress granules are dynamic and reversible assemblies, but in neurodegeneration they become pathological and persistent. The molecular mechanisms governing this transition from physiological to pathological states remain unexplained, yet understanding this could reveal therapeutic targets.\n\nGap type: unexplained_observation\nSource paper: G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Granules. (2020, Cell, PMID:32302571)”, “score”: 0.434, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-041428-4c4414ad”, “quality_score”: 0.843, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88_20260413-225852”, “title”: “The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and HIF-1α stabilization remains unexplained. Understanding this connection is critical for developing targeted therapies that could prevent early pathogenic events in VCP-ALS.\n\nGap type: unexplained_observation\nSource paper: Hypoxic stress is an early pathogenic event in human VCP-mutant ALS astrocytes. (2026, Stem cell reports, PMID:41349534)”, “score”: 0.413, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-150500-e110aab9_20260413-225442”, “title”: “This study identifies oligodendrocytes as drivers of neuroinflammation in PD, contradicting the established paradigm that microglia are the primary neuroinflammatory cells. Understanding this cell-type hierarchy is crucial for targeting the right therapeutic cells.\n\nGap type: contradiction\nSource paper: Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson’s disease via the prosaposin-GPR37-IL-6 axis. (2025, Cell Rep, PMID:39913287)”, “score”: 0.408, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-150500-e110aab9”, “quality_score”: 0.79, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.408, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}